scholarly journals Terapia Física Descongestiva no tratamento do linfedema secundário ao câncer de mama: uma revisão sistemática / Decongestive Physical Therapy in the treatment of secondary breast cancer lymphedema: a systematic review

2020 ◽  
Vol 14 (53) ◽  
pp. 330-340
Author(s):  
Marilange Araújo de Almeida Souza ◽  
Aline Marques Piloto ◽  
Rosana Porto Cirqueira
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Physical Therapy ◽  
Cáncer De Mama ◽  
Secondary Breast Cancer ◽  
De Medicina

Resumo: O linfedema secundário é disfunção linfática crônica caraterizado como uma consequência do processo cirúrgico do câncer de mama que pode ser tratado por procedimento cirúrgico ou conservador. O objetivo foi realizar uma revisão sistemática da literatura sobre a utilização da terapia física descongestiva no tratamento do linfedema secundário e seus efeitos na redução do linfedema. Trata-se de uma revisão sistemática de literatura com artigos publicados nas bases de dados do Scientific Eletronic Library Online, Biblioteca Nacional de Medicina, Literatura Latino-Americana e Google Acadêmico, nos anos de 2010 a 2019. Foram selecionados 10 estudos que demonstraram efeitos positivos da terapia física descongestiva no tratamento do linfedema secundário e seus efeitos benefícios na redução do linfedema. A revisão sistemática comprovou os terapia física descongestiva é uma aliada no tratamento conservador do linfedema secundário de câncer de m

Uso del modelo Gail para identificar mujeres con alto riesgo de desarrollar cáncer de mama

2018 ◽  
Vol 25 (3) ◽  
Author(s):  
Elizabeth Zurisadai García González ◽  
Jorge Alejandro Alcalá Molina ◽  
Alyne Mendo Reygadas
Keyword(s):  
Breast Cancer ◽  
Risk Assessment ◽  
Breast Cancer Risk ◽  
Assessment Tool ◽  
Cancer Risk Assessment ◽  
Cáncer De Mama ◽  
Breast Cancer Risk Assessment ◽  
Factores De Riesgo ◽  
Las Mujeres ◽  
De Medicina

<p><strong>Objetivos: </strong>identificar mujeres con alto riesgo de desarrollar cáncer de mama (CaMa) con base en el modelo Gail. <strong>Métodos: </strong>estudio transversal analítico en 154 mujeres de 35 a 64 años, que acudieron a consulta externa de medicina familiar de marzo a noviembre de 2016. Se les interrogó sobre factores de riesgo para cáncer de mama y estos se analizaron en la calculadora electrónica <em>Breast Cancer Risk Assessment Tool</em> (Herramienta para evaluar el riesgo de cáncer de mama), basada en el modelo Gail. Un puntaje mayor o igual a 1.66 representa alto riesgo de desarrollar CaMa en los cinco años siguientes. <strong>Resultados: </strong>se identificaron 24 pacientes (16%) con alto riesgo de desarrollar CaMa. Las mujeres que refirieron familiares de primer grado con CaMa presentaron puntajes elevados. A las mujeres identificadas se les derivó con su médico familiar y gracias al seguimiento se diagnosticó a una paciente con CaMa, actualmente en tratamiento. <strong>Conclusiones: </strong>la proporción de mujeres con alto riesgo de desarrollar cáncer de mama en los cinco años siguientes, medido por el modelo Gail, fue elevada. Se propone incorporar el instrumento en el primer nivel de atención, ya que el tiempo de ejecución es breve y permite la identificación y derivación oportuna de mujeres con alta sospecha de padecer esta enfermedad para la realización de pruebas confirmatorias.</p>

scholarly journals PERFIL MOLECULAR DO CÂNCER DE MAMA TRIPLO NEGATIVO: UMA REVISÃO SISTEMÁTICA / MOLECULAR PROFILE OF NEGATIVE TRIPLE BREAST CANCER: A SYSTEMATIC REVIEW

2020 ◽  
Vol 6 (10) ◽  
pp. 82283-82303
Author(s):  
Emanuela Sinimbu Silva Rossoni ◽  
Marcela Barbosa Hércules ◽  
Julliete Cristina de Oliveira ◽  
Areta Agostinho Rodrigues de Souza ◽  
Hugo de Carlos Maciel Rossoni
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Cáncer De Mama ◽  
Molecular Profile

scholarly journals Access to systemic anti-cancer therapies for women with secondary breast cancer—protocol for a mixed methods systematic review

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Sally Anne Pearson ◽  
Sally Taylor ◽  
Antonia Marsden ◽  
Janelle Yorke
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Mixed Methods ◽  
Contextual Factors ◽  
Cochrane Library ◽  
Evidence Based ◽  
Cancer Therapies ◽  
Anti Cancer ◽  
Unwarranted Variation ◽  
Secondary Breast Cancer

Abstract Background It is well recognised that access and receipt of appropriate guideline recommended treatment with systemic anti-cancer therapies for secondary breast cancer is a key determinant in overall survival. Where there is disparity in access this may result in unwarranted variation and disparity in outcomes. Individual, clinical and wider contextual factors have been associated with these disparities, however this remains poorly understood for women with secondary breast cancer. The purpose of the review is to examine individual, clinical and contextual factors which influence access to evidence-based systemic anti-cancer therapies for women with secondary breast cancer. This will include barriers and facilitators for access and receipt of treatment and an exploration of women and clinicians experience and perspectives on access. Methods A mixed methods approach with a segregated design will be used to examine and explore factors which influence access to systemic anti-cancer therapies for women with secondary breast cancer. Electronic databases to be searched from January 2000 onwards will be EBSCO CINAHL Plus, Ovid MEDLINE, Ovid EMBASE, PsychINFO and the Cochrane Library and JBI database. This will include NHS Evidence which will be searched for unpublished studies and gray literature. Title and abstract citations and full-text articles will be screened by the author and second reviewer. Data will be extracted by the author and validated by the second reviewer. An overarching synthesis will be produced which brings together quantitative and qualitative findings. Methodological quality and risk of bias will be assessed using the Mixed Methods Appraisal Tool. Discussion Understanding individual, clinical and wider contextual factors associated with access and receipt of systemic anti-cancer therapies for secondary breast cancer is a complex phenomenon. These will be examined to determine any association with access. Review findings will be used to guide future research in this area and the development of an evidence-based service level intervention designed to address unwarranted variation in access based upon the Medical Research Council (MRC) approach to the development, implementation and evaluation of complex interventions. Systematic review registration The review protocol has been registered in PROSPERO CRD42020196490.

scholarly journals Factors related to the recovery of functional capacity in women with breast cancer: systematic review (Factores relacionados con la recuperación de la capacidad funcional en mujeres con cáncer de mama: revisión sistemática)

2021 ◽  
Vol 16 (48) ◽  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Functional Capacity ◽  
Methodological Quality ◽  
Well Being ◽  
Early Rehabilitation ◽  
Cáncer De Mama ◽  
Revisión Sistemática ◽  
Bienestar Psicologico

The objective of this review was to consolidate the available evidence about the factors related to the recovery of functional capacity (FC) in women with breast cancer, based the PRISMA declaration criteria. The quality of the studies was assessed using the New Castle Ottawa and JADAD scales. 11 studies were included: seven experimental and four cohort follow-ups. Psychological, clinical, and treatment factors related to FC recovery, were identified. However, some results come from studies with low methodological quality. Additionally, the findings are not comparable because they were evaluated using different instruments. In conclusion, the recovery of FC to require considering individual and interventions factors, as psychological well-being and early rehabilitation. Is necessary to standardize the instruments to evaluate FC in women with breast cancer, and to increase the quality of the research about this topic. === El objetivo de esta revisión fue consolidar la evidencia disponible sobre los factores relacionados con la recuperación de la capacidad funcional (CF) en mujeres con cáncer de mama de acuerdo a los criterios de la declaración de PRISMA. La calidad de los estudios se evaluó utilizando las escalas New Castle Ottawa y JADAD. Se incluyeron 11 estudios: 7 experimentales y 4 seguimientos de cohortes. Identificamos factores psicológicos, clínicos y de tratamiento relacionados con la recuperación de CF, sin embargo, algunos resultados provienen de estudios con baja calidad metodológica. Además, los resultados no son comparables, porque fueron evaluados utilizando diferentes instrumentos. En conclusión, la recuperación de la FC requiere considerar factores individuales y de intervención, como el bienestar psicológico y la rehabilitación temprana, pero es necesario estandarizar los instrumentos para evaluar la CF en mujeres con cáncer de mama y aumentar la calidad de la investigación sobre este tema.

Effectiveness of Postoperative Physical Therapy for Upper-Limb Impairments After Breast Cancer Treatment: A Systematic Review

2015 ◽  
Vol 96 (6) ◽  
pp. 1140-1153 ◽  
Author(s):  
An De Groef ◽  
Marijke Van Kampen ◽  
Evi Dieltjens ◽  
Marie-Rose Christiaens ◽  
Patrick Neven ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Physical Therapy ◽  
Cancer Treatment ◽  
Upper Limb ◽  
Breast Cancer Treatment ◽  
Postoperative Physical Therapy

scholarly journals QUALITY OF LIFE RELATED TO BREAST CANCER IN WOMEN IN POSTMENOPAUSE: A SYSTEMATIC REVIEW

2021 ◽  
Vol 2 (6) ◽  
pp. e26471
Author(s):  
Alexsandra Ribeiro Ferreira ◽  
Laura Gonçalves Faustino ◽  
Karina Mary De Paiva ◽  
Patricia Haas ◽  
Ana Ines Gonzales
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Systematic Review ◽  
Google Scholar ◽  
Cáncer De Mama

Objetivo: Verificar a qualidade de vida relacionada ao câncer de mama na pós-menopausa em mulheres usuárias de TH, por meio de revisão sistemática. Métodos: Para a seleção do estudo, a combinação [(terapia de reposição hormonal) AND (uso) AND (câncer de mama) AND (mulheres na menopausa) AND (qualidade de vida) AND (ensaio clínico randomizado)] foi usada. A busca foi realizada nas bases de dados Medline, LILACS, Bireme, SciELO, ScienceDirect e Google Scholar na forma de busca cinza. Foram incluídos artigos randomizados, sem restrição de idioma, publicados entre janeiro de 2010 e março de 2020, com pontuação mínima de 10 na escala modificada da literatura. Foram excluídos os artigos que não continham título, resumo ou corpo do artigo relacionado ao objetivo da pesquisa. Resultado: Foram recuperados 1217 artigos, porém dois artigos atenderam aos critérios de inclusão e foram classificados como de alta qualidade. Foi demonstrado que a TH aumenta o risco de desenvolver câncer de mama durante a pós-menopausa. Conclusão: A TH combinada com diferentes progestagênios melhora os sintomas causados ​​pela pós-menopausa. Porém, deve-se avaliar as vantagens e desvantagens do uso entre as mulheres, principalmente quando estas apresentam algum fator de risco para o desenvolvimento da doença. Taxas mais baixas de risco de câncer de mama foram observadas quando o HT foi administrado apenas com estrogênio

scholarly journals Access to Systemic Anti-cancer Therapies for Women With Secondary Breast Cancer - Protocol for a Mixed Methods Systematic Review

2020 ◽  
Author(s):  
Sally Anne Pearson ◽  
Sally Taylor ◽  
Antonia Marsden ◽  
Janelle Yorke
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Mixed Methods ◽  
Data Extraction ◽  
Contextual Factors ◽  
Cancer Therapies ◽  
Factors Associated ◽  
Anti Cancer ◽  
Unwarranted Variation ◽  
Secondary Breast Cancer

Abstract Background:It is well recognised that access and receipt of appropriate guideline recommended treatment with systemic anti-cancer therapies for secondary breast cancer is a key determinant in overall survival. Where there is disparity in access this may result in unwarranted variation and disparity in outcomes. Individual, clinical and wider contextual factors have been associated with these disparities, however this remains poorly understood for women with secondary breast cancer. The purpose of the review is to address this gap by bringing together the available quantitative and qualitative evidence to examine factors associated with access to systemic anti-cancer therapies for women with secondary breast cancer and explore barriers and facilitators in relation to women and clinicians experience of access.Methods: A mixed methods approach with a segregated design will be used to examine and explore factors which influence access to systemic anti-cancer therapies for women with secondary breast cancer. Quantitative and qualitative appraisal, analysis and syntheses will be conducted discretely prior to final integration of findings. The review will use a comprehensive search strategy to search published and gray literature. Titles and abstracts will be screened against the eligibility criteria and full text articles will be retrieved for all records that meet the inclusion criteria. A data extraction tool will be developed, piloted and refined prior to full data extraction. Methodological quality and risk of bias will be assessed using the Mixed Methods Appraisal Tool. Discussion:Understanding individual, clinical and wider contextual factors associated with access and receipt of systemic anti-cancer therapies for secondary breast cancer is a complex phenomenon. These will be examined to determine any association with access. Review findings will be used to guide future research in this area and the development of an evidence-based service level intervention designed to address unwarranted variation in access based upon the Medical Research Council (MRC) approach to the development, implementation and evaluation of complex interventions.Systematic review registration:The review protocol has been registered in PROSPERO CRD42020196490

scholarly journals QUALIDADE DE VIDA DE HOMENS COM CÂNCER DE MAMA: REVISÃO SISTEMÁTICA / QUALITY OF LIFE OF MEN WITH BREAST CANCER: SYSTEMATIC REVIEW

2020 ◽  
Vol 6 (9) ◽  
pp. 71609-71626
Author(s):  
Ana Paula Schmitz Rambo ◽  
Laura Faustino Gonçalves ◽  
Fernanda Soares Aurélio Pattat ◽  
Karina Mary Paiva ◽  
Ana Inês Gonzáles ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Systematic Review ◽  
Cáncer De Mama
Sign in / Sign up

Export Citation Format

Share Document